Therapeutic Advances in Respiratory Disease

eISSN: 1753-4666pISSN: 1753-4658
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
6.8
H-Index
46
Impact Factor
< 5
SJR
Q1Pharmacology (medical)
SNIP
1.42
6
Time to Publish
time-to-publish View Chart
8  Mo

Journal Specifications

Overview
  • Publisher
    SAGE PUBLICATIONS LTD
  • Language
    English
  • Frequency
    Continuous publication
  • Article Processing Charges
    USD 2300
  • Publication Time
    15
  • Editorial Review Process
    Open peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

check-iconMeets Top Publisher Standards: Essential for leading journals like Elsevier.
check-iconEnhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
check-iconTailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn morethumb-icon 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 0%
4-6 26%
7-9 48%
>9 27%

Topics Covered

Pulmonary hypertension
Air leak
Bronchoscopy
Cystic fibrosis
Idiopathic pulmonary fibrosis
Respiratory failure
Observational study
COPD
Systematic review
Airway inflammation
Confidence interval
Dexamethasone
Inhalation
Pneumonia
Nasal polyps
Home nebulizers
Mechanical ventilation
Odds ratio
Treprostinil
Asthma control

Recently Published Papers

FAQs

Since when has Therapeutic Advances in Respiratory Disease been publishing? Faqs

The Therapeutic Advances in Respiratory Disease has been publishing since 2007 till date.

How frequently is the Therapeutic Advances in Respiratory Disease published? Faqs

Therapeutic Advances in Respiratory Disease is published Continuous publication.

What is the H-index. SNIP score, Citescore and SJR of Therapeutic Advances in Respiratory Disease? Faqs

Therapeutic Advances in Respiratory Disease has a H-index score of 46, Citescore of 6.8, SNIP score of 1.42, & SJR of Q1

Who is the publisher of Therapeutic Advances in Respiratory Disease? Faqs

The publisher of Therapeutic Advances in Respiratory Disease is SAGE PUBLICATIONS LTD.

How can I view the journal metrics of Therapeutic Advances in Respiratory Disease on editage? Faqs

For the Therapeutic Advances in Respiratory Disease metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Therapeutic Advances in Respiratory Disease? Faqs

The eISSN number is 1753-4666 and pISSN number is 1753-4658 for Therapeutic Advances in Respiratory Disease.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Pulmonary hypertension, Air leak, Bronchoscopy, Cystic fibrosis, Idiopathic pulmonary fibrosis, Respiratory failure, Observational study, COPD, Systematic review, Airway inflammation, Confidence interval, Dexamethasone, Inhalation, Pneumonia, Nasal polyps, Home nebulizers, Mechanical ventilation, Odds ratio, Treprostinil, Asthma control.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.